EU TPD Revision: What Vape Brands Should Prepare for Now

The EU’s Tobacco Products Directive (TPD) revision has officially entered public consultation, with feedback open until August 14, 2026.

For vape brands and manufacturers, this is one of the most important regulatory developments in Europe in the last decade.

Why?

Because this revision may reshape how nicotine products are defined, approved, and sold across the EU.

The original TPD framework was created when the vape market looked very different.

Back then:

• Disposable vapes were still emerging
• Nicotine pouches had limited market share
• Online sales were far less influential

Today, the market has changed dramatically.

Regulators are now trying to close the gap.

What could change?

Current signals suggest four major areas:

1. Wider product coverage

The EU may regulate all nicotine-related products, including:

• Nicotine pouches
• Nicotine lozenges
• Nicotine-free e-liquids
• Other alternative nicotine formats

This would significantly expand compliance requirements.

2. Closing loopholes

Products designed around current limits may face tighter control:

• 2ml + 10ml bundled systems
• Zero-nicotine refill systems
• Cross-border online sales structures

These models are now under closer review.

3. Stronger product standards

Future rules may unify:

• Nicotine limits
• Ingredient disclosure
• Packaging warnings
• Notification systems

Plain packaging is also increasingly part of the discussion.

4. Tighter marketing controls

Digital promotion may become much harder.

This includes:

• Social media marketing
• Influencer campaigns
• Online advertising
• Cross-border digital targeting

For many brands, this could directly affect growth.

Why should manufacturers care now?

Because regulatory change always starts before enforcement.

If TPD3 moves forward as expected, companies may need to prepare:

✔ Product reformulation ✔ Packaging redesign ✔ Updated toxicology documentation ✔ Faster compliance workflows

Early preparation reduces future risk.

Late preparation increases cost.

At YTOO Biotech, we continue monitoring EU regulatory developments and supporting partners with TPD registration, UFI documentation, and compliant product development.

In Europe, compliance is becoming a competitive advantage.